Study title: Oral nystatin profilaxis to prevent invasive candidiasis in neonatal intensive care unit 2006
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Bacterial Infections and Mycoses [01] | |||||
Brands: | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: NYSTATIN | |||||
ATC code: A07AA02 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
Y | Y | - | - | - |